CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast
Main Authors: | , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Medknow Publications & Media Pvt Ltd
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4248382/ |
id |
pubmed-4248382 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-42483822014-12-05 CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast Rathore, Ankita Singh Kumar, Sandeep Konwar, Rituraj Makker, Annu Negi, M.P.S. Goel, Madhu Mati Original Article Medknow Publications & Media Pvt Ltd 2014-09 /pmc/articles/PMC4248382/ /pubmed/25366203 Text en Copyright: © Indian Journal of Medical Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Rathore, Ankita Singh Kumar, Sandeep Konwar, Rituraj Makker, Annu Negi, M.P.S. Goel, Madhu Mati |
spellingShingle |
Rathore, Ankita Singh Kumar, Sandeep Konwar, Rituraj Makker, Annu Negi, M.P.S. Goel, Madhu Mati CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast |
author_facet |
Rathore, Ankita Singh Kumar, Sandeep Konwar, Rituraj Makker, Annu Negi, M.P.S. Goel, Madhu Mati |
author_sort |
Rathore, Ankita Singh |
title |
CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast |
title_short |
CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast |
title_full |
CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast |
title_fullStr |
CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast |
title_full_unstemmed |
CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast |
title_sort |
cd3+, cd4+ & cd8+ tumour infiltrating lymphocytes (tils) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast |
description |
|
publisher |
Medknow Publications & Media Pvt Ltd |
publishDate |
2014 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4248382/ |
_version_ |
1613162249581494272 |